Premium
Application of Einstein matrix medical treatment for HIVv/HCV therapy (668.4)
Author(s) -
Einstein George,
Echavarria Louis,
Tulp Orien
Publication year - 2014
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.28.1_supplement.668.4
Subject(s) - bacteria , somatic cell , intracellular , asymptomatic , chemistry , medicine , microbiology and biotechnology , biology , biochemistry , pathology , genetics , gene
Biophotonic Therapy [Photo‐therapy] uses ultraviolet light, is a safe, non‐intrusive, drug free, cost effective, and nonspecific treatment for a broad spectrum of bacterial and viral infections Biophotonics generates and harnesses light (photons) to image, detect and manipulate biological materials, and can also be applied as a biological probe for molecular mechanisms, function and structure. Einstein Clinical Laboratories [ECL] has perfected a proprietary therapy of purification blood called Einstein's Matrix Treatment (EMT) also referred to as the EMC‐ 2001E [named for its developer & inventor, Dr. George P. Einstein]. The EMT approach is to target and destroy viruses or bacteria by the application of a specific amount of photon energy that is not harmful for healthy cells. The parameters that targeted the pathogens are specific wavelength, intensity and time of exposure to the light targets the physical & chemical structure of bacteria resulting in their death via a UV‐mediated intracellular coagulative process. Bacteria are much smaller than somatic cells, their shells are thinner, and are more susceptible to UV Light. Also, the amino acids phe and tyr are present in the micro‐organisms in 5x greater amounts than in somatic cells which are largely unaffected by the UV process. In pilot studies with HIV or both HIV and HCV viruses, patients remained asymptomatic and virus free throughout a 10 year followup. UVC irradiation of blood had an inhibitory influence on mRNA expression of inflammatory cytokines, IL‐1, IL‐6 whereas it stimulated production of IL‐b. Pro‐inflammatory cytokines are engaged in migration of cells to the inflammation area, as well as in stimulation, proliferation and differentiation of cells and a decrease in inflammatory markers. In conclusion, HVB was found to be safe and beneficial for patients, while UVC lends promise to the treatment of a broad range of infectious illnesses. Grant Funding Source : Institutional Resources